Concourse Financial Group Securities’s Teva Pharmaceuticals TEVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Hold |
0
| – | – | – | 7552 |
|
|
2024
Q4 | – | Hold |
0
| – | – | – | 7945 |
|
|
2024
Q3 | – | Hold |
0
| – | – | – | 7938 |
|
|
2024
Q2 | – | Hold |
0
| – | – | – | 7947 |
|
|
2024
Q1 | – | Hold |
0
| – | – | – | 7944 |
|
|
2023
Q4 | – | Hold |
0
| – | – | – | 7877 |
|
|
2023
Q3 | – | Hold |
0
| – | – | – | 7679 |
|
|
2023
Q2 | – | Hold |
0
| – | – | – | 7488 |
|
|
2023
Q1 | – | Hold |
0
| – | – | – | 7226 |
|
|
2022
Q4 | – | Hold |
0
| – | – | – | 7241 |
|
|
2022
Q3 | – | Hold |
0
| – | – | – | 7062 |
|
|
2022
Q2 | – | Hold |
0
| – | – | – | 6977 |
|
|
2022
Q1 | – | Hold |
0
| – | – | – | 6841 |
|
|
2021
Q4 | – | Sell |
-33
| Closed | – | – | 6753 |
|
|
2021
Q3 | $0 | Hold |
33
| – | – | ﹤0.01% | 6540 |
|
|
2021
Q2 | $0 | Hold |
33
| – | – | ﹤0.01% | 6307 |
|
|
2021
Q1 | $0 | Sell |
33
-1,100
| -97% | – | ﹤0.01% | 6087 |
|
|
2020
Q4 | $11K | Sell |
1,133
-481
| -30% | -$4.67K | ﹤0.01% | 1665 |
|
|
2020
Q3 | $15K | Buy |
1,614
+481
| +42% | +$4.47K | ﹤0.01% | 1452 |
|
|
2020
Q2 | $14K | Buy |
1,133
+1,100
| +3,333% | +$13.6K | ﹤0.01% | 1408 |
|
|
2020
Q1 | $0 | Hold |
33
| – | – | ﹤0.01% | 5482 |
|
|
2019
Q4 | $0 | Buy |
+33
| New | – | ﹤0.01% | 5397 |
|
|
2019
Q3 | – | Sell |
-913
| Closed | -$8K | – | 5230 |
|
|
2019
Q2 | $8K | Sell |
913
-1,342
| -60% | -$11.8K | ﹤0.01% | 1576 |
|
|
2019
Q1 | $34K | Buy |
2,255
+1,080
| +92% | +$16.3K | ﹤0.01% | 1032 |
|
|
2018
Q4 | $18K | Buy |
1,175
+33
| +3% | +$506 | ﹤0.01% | 1209 |
|
|
2018
Q3 | $25K | Buy |
+1,142
| New | +$25K | 0.01% | 797 |
|